A Phase IIIb/IV Safety Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Advanced Malignancies
Administered By
Awarded By
Contributors
- Ready, Neal Edward Principal Investigator
Start/End
- January 17, 2017 - October 31, 2021